Marc Van Dijk
Chief Scientific Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | MiNK Therapeutics, Inc. (INKT) | Strategic Consultant and Scientific Advisory Board Member; Former Chief Scientific Officer | $341,796 | $402,479 |
| 2023 | MiNK Therapeutics, Inc. (INKT) | Strategic Consultant and Scientific Advisory Board Member; Former Chief Scientific Officer | $333,989 | $568,829 |
| 2022 | MiNK Therapeutics, Inc. (INKT) | Chief Scientific Officer | $252,334 | $651,174 |
| 2021 | MiNK Therapeutics, Inc. (INKT) | Chief Scientific Officer | — | $107,074 |
Earnings-call appearances
-
MiNK Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-13
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-14
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q4 FY2023 Earnings Call2024-03-21
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-09
MiNK Therapeutics, Inc. (INKT)
-
MiNK Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-11
MiNK Therapeutics, Inc. (INKT)